Ogivri (trastuzumab)

pCPA File Number: 21129
Negotiation Status:
Concluded with an LOI
Indication(s):
early breast cancer/metastatic breast cancer/metastatic gastric cancer
Sponsor/Manufacturer:
BGP Pharma ULC
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: